Sign in

CIK 0001671584

  • Non-accelerated filer
  • Smaller reporting company

Aptevo Therapeutics Inc.

Sign in to watch
Ticker
APVO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811567056
Phone
+1 206-838-0500
Business address
2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-02-18 Adelman Michael SVP, Commercial Operations Grant or award · Stock Option (right to buy) +134,800 134,800
2019-11-01 Adelman Michael SVP, Commercial Operations Grant or award · Stock Option (right to buy) +114,247 114,247
2019-03-01 Adelman Michael SVP, Commercial Operations Exercise or conversion +7,318 72,821
2019-03-01 Adelman Michael SVP, Commercial Operations Shares withheld for taxes −2,395 $1.57 $4K 70,426
2019-03-01 Adelman Michael SVP, Commercial Operations Exercise or conversion · Restricted Stock Unit −7,318 0
2019-02-28 Adelman Michael SVP, Commercial Operations Grant or award · Stock Option (right to buy) +67,400 67,400

Page 1 of 1 · 6 trades